Extensive necrosis of visceral melanoma metastases after immunotherapy

BACKGROUND: The prognosis for metastatic melanoma remains poor even with traditional decarbazine or interferon therapy. 5-year survival is markedly higher amongst patients undergoing metastatectomy. Unfortunately not all are suitable for metastatectomy. Alternative agents for systemic therapy have,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoeter, David, de Liguori Carino, Nicola, Marshall, Ernest, Poston, Graeme J, Wu, Andrew
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292185/
https://www.ncbi.nlm.nih.gov/pubmed/18318916
http://dx.doi.org/10.1186/1477-7819-6-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292185/
https://www.ncbi.nlm.nih.gov/pubmed/18318916
http://dx.doi.org/10.1186/1477-7819-6-30

Ejemplares similares